TransMedics TMDX
NASDAQ TMDX
$79.79 +1.15 (+1.46%)
At close: Oct 2, 2026 · 4:00 PM EDT

TransMedics (TMDX) Gains from Sales and Divestitures (2025)

Updated

TransMedics' Gains from Sales and Divestitures came in at -$80,000 for FY2025, compared with -$17,000 in FY2024.

Analysis

TransMedics (TMDX) Gains from Sales and Divestitures (2025) Analysis & Trends

  • Per Business Quant, earlier years put Gains from Sales and Divestitures at -$17,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 TransMedics 2.76 Bn 874.10 Mn 113.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -80,000.00
API Access

TransMedics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TMDX&period=max&api_key=YOUR_API_KEY